CCP-virus is mutated into a more contagious and lethal strain, but the World Health Organization is downplaying its airborne transmission. A gain-of-function researcher, who co-authored a paper on the effectiveness of zinc in treating coronavirus infections ten years ago, has remained silent.
Hydroxcholorquine+azithromycin+zinc and ivermectin have shown strong promise as an affordable and effective treatment, but there is a political and academic champaign to downplay its effectiveness.
From what we have learned so far, herd immunity without a vaccine may be harder to achieve than previously anticipated.
In 2010, coronavirus researchers published a pager on the effectiveness of zinc
Zn(2+) Inhibits Coronavirus and Arterivirus RNA Polymerase Activity in Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
The co-author of the paper on zinc, Ralph S Baric, is a “gain-of-function” researcher. It is quite puzzling that he has remained silent on the effectiveness of zinc during the pandemic.
Please watch the video for the latest news and developments on the CCP-virus including mutation, airborne transmission, treatment, herd immunity and Spain’s giant seroprevalence testing, etc